放射抵抗前列腺癌细胞组的miRNA失调特征分析
本研究分析了一组具有不同放射敏感性的22RV1前列腺癌细胞(包括缺氧H-22Rv1、经2 Gy分次照射衍生的RR-22Rv1、年龄匹配的AMC-22Rv1及野生型WT-22Rv1)的miRNA表达谱,以识别与放射抵抗表型相关的共同miRNA。结果显示,照射后克隆存活增加伴随miRNA表达模式的显著改变,并鉴定出多个候选miRNA,可能用于开发前列腺癌放疗预后生物标志物。
要点
- RR-22Rv1细胞中miR-221上调、miR-4284下调最显著。
- AMC-22Rv1细胞中miR-31和miR-200c显著失调。
- 缺氧H-22Rv1细胞中miR-210表达倍数变化最高。
核心结论
- 本研究鉴定出与放射抵抗前列腺癌表型相关的候选miRNA,可用于开发新的预后生物标志物。
研究设计与样本
- 对一组22RV1细胞(缺氧H-22Rv1、RR-22Rv1、AMC-22Rv1和WT-22Rv1)生成miRNA表达谱并进行交叉分析。
- RR-22Rv1细胞由WT-22Rv1细胞经2 Gy分次重复照射衍生。
主要发现
- 照射后克隆存活增加与miRNA表达模式的显著改变相关。
- 与WT-22Rv1相比,RR-22Rv1中miR-221上调、miR-4284下调,AMC-22Rv1中miR-31和miR-200c显著失调。
- 与RR-22Rv1相比,缺氧H-22Rv1中miR-200c下调最显著;与WT-22Rv1相比,H-22Rv1中miR-210表达倍数变化最高。
- miR-200a是RR-22Rv1与AMC-22Rv1之间唯一差异表达的miRNA。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: miRNAs are increasingly associated with the aggressive phenotype of prostate tumours. Their ability to control radiobiologically-relevant cellular processes strengthens their potential as novel markers of response to radiation therapy. PURPOSE: To identify miRNAs associated with increased clonogenic survival following radiation exposure. MATERIAL AND METHODS: The miRNA expression profiles of a panel of 22RV1 cells with varying levels of radiosensitivities (hypoxic H-22Rv1 cells, RR-22Rv1 cells derived from WT-22Rv1 cells through 2-Gy fractionated repeated exposure, the associated aged matched cells (AMC-22Rv1) and the WT-22Rv1 cell lines) were generated and cross-analysed to identify common miRNAs associated with a radioresistant phenotype. RESULTS: Increased clonogenic survival following irradiation was associated with significant modifications in miRNA expression pattern. miR-221 (up) and miR-4284 (down) in RR-22Rv1 and MiR-31 and miR-200c in AMC-22Rv1 were the most uniquely significantly deregulated miRNAs when compared to WT-22Rv1 cells. miR-200c ranked as the most downregulated miRNAs in hypoxic, when compared to RR-22Rv1 cells. miR-200a was the only differentially expressed miRNA between RR-22Rv1 and AMC-22Rv1 cells. miR-210 yielded the highest fold change in expression in H-22Rv1, when compared to WT-22RV1 cells. CONCLUSION: This study identifies candidate miRNAs for the development of novel prognostic biomarkers for radiotherapy prostate cancer patients.
引用
- McDermott N, Meunier A, Wong S, et al. Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs. Clin Transl Radiat Oncol. 2017. PMID: 29658003. doi:10.1016/j.ctro.2017.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。